Fully automated preparation of 68Ga-PSMA-11 at curie level quantity using cyclotron-produced 68Ga for clinical applications
Authors:
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 155, 108936
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literatureMinerva Urology and Nephrology, 2018
- 68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- 68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic reviewWorld Journal of Urology, 2018
- Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer RecurrenceJournal of Nuclear Medicine, 2017
- Production of copper-64 and gallium-68 with a medical cyclotron using liquid targetsModern Physics Letters A, 2017
- Generator Breakthrough and Radionuclidic Purification in Automated Synthesis of 68Ga-DOTANOCCurrent Radiopharmaceuticals, 2013
- [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECHEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Synthesis, stabilization and formulation of [177Lu]Lu-AMBA, a systemic radiotherapeutic agent for Gastrin Releasing Peptide receptor positive tumorsApplied Radiation and Isotopes, 2008
- Reaction mechanisms in the radiolysis of peptides, polypeptides, and proteinsChemical Reviews, 1987
- Radical scavengers and the stability ofThe International Journal of Applied Radiation and Isotopes, 1982